We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Sign up to read this article for FREE!

After signing up, you'll start to receive regular news updates from us.

Neurology Positioned to Benefit from Progress in Regenerative Therapies

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Diseases and injuries that affect central nervous system neurons are among the illnesses that are hardest to cure.

Their frequency increases dramatically with age, and morbidity associated with neurological disorders is expected to rise dramatically in the coming years in lockstep with the aging of the population.

Evidence that neurogenesis persists beyond the embryonic and early developmental periods has led to a number of programs in academia and the commercial sector that seek to stimulate the differentiation and growth of adult neural stem cells.

A number of small companies are focusing on the development of methods and tools to enhance the regenerative responses of axons following different kinds of acute insults or chronic damage resulting from neurological conditions.

Advances in neurogenesis and nerve regeneration are being chaperoned by a number of enabling technologies such as functional mapping, which is already being used in a number of clinical settings, and enhanced diagnostic imaging.

These developments will accelerate the pace of clinical successes in a segment with significant market potential.

These findings are contained in a comprehensive report. Neurogenesis and Nerve Regeneration contains detailed and insightful analysis of programs, participants and prospects in this evolving sector.